Drug intelligence / Profile preview

yishen zengmo decoction

Development stage: Unknown
Lead developer: Xiyuan Hospital
Administration: Oral

Overview

Yishen Zengmo Decoction is a traditional Chinese medicine (TCM) herbal formula developed at Xiyuan Hospital, China Academy of Chinese Medical Sciences, based on the clinical experience of Cai Lianxiang. It is primarily indicated for the treatment of moderate to severe intrauterine adhesions (IUA) in patients exhibiting the TCM pattern of kidney deficiency and blood stasis. The decoction is typically used in a phased treatment approach following hysteroscopic adhesiolysis, often administered sequentially after Yiqi Xiaozheng Decoction. Its therapeutic goals include promoting endometrial growth, improving endometrial receptivity, and reducing the recurrence of adhesions by tonifying the kidney and resolving blood stasis.

Other names: Yishen Zengmo Tang益肾增膜汤

Beyond the preview

Go deeper on yishen zengmo decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on yishen zengmo decoction.

Explore the full profile